fluorescein-5-isothiocyanate has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Kiso, Y; Lloyd, GK; Miller, BR; Neuteboom, ST; Nicholson, B; Palladino, MA | 1 |
| Cao, X; Guo, R; Shen, M; Shi, X; Wang, Y; Zhang, M | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and fosbretabulin
| Article | Year |
|---|---|
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Colchicine; Dextrans; Diketopiperazines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; HL-60 Cells; HT29 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Jurkat Cells; Microtubules; Neoplasms; Piperazines; Stilbenes; Time Factors; Tubulin; Vincristine | 2006 |
Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.
Topics: Analysis of Variance; Antineoplastic Agents; Cell Survival; Dendrimers; Fluorescein-5-isothiocyanate; Folic Acid; Humans; KB Cells; Microscopy, Phase-Contrast; Solubility; Stilbenes | 2011 |